Detalhe da pesquisa
1.
Pharmacokinetics and Bioequivalence of Isavuconazole Administered as Isavuconazonium Sulfate Intravenous Solution via Nasogastric Tube or Orally in Healthy Subjects.
Antimicrob Agents Chemother
; 65(9): e0044221, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181478
2.
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a ß3-adrenoceptor agonist for treatment of overactive bladder.
Int J Clin Pharmacol Ther
; 50(11): 838-50, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22943933
3.
Effect of enzalutamide on PK of P-gp and BCRP substrates in cancer patients: CYP450 induction may not always predict overall effect on transporters.
Clin Transl Sci
; 15(5): 1131-1142, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35118821
4.
Time-dependent inhibitory effects of (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(2-oxopropyl)-11,28-dioxa-4-azatricyclo[22.3.1.0(4.9)]octacos-18-ene-2,3,10,16-tetrone (FK1706), a novel nonimmunosuppressive immunophilin ligand, on CYP3A4/5 activity in humans in vivo and in vitro.
Drug Metab Dispos
; 38(2): 249-59, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19889885
5.
Investigation of Potential Drug-Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis.
Clin Drug Investig
; 40(9): 827-838, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591978
6.
Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor.
Clin Pharmacokinet
; 59(10): 1273-1290, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32304015
7.
Pharmacokinetic drug interaction study between overactive bladder drugs mirabegron and tolterodine in Japanese healthy postmenopausal females.
Drug Metab Pharmacokinet
; 31(6): 411-416, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27829538
8.
Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor.
Clin Pharmacokinet
; 60(9): 1251, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297319
9.
Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
Clin Ther
; 35(3): 333-41, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497763
10.
Effect of renal or hepatic impairment on the pharmacokinetics of mirabegron.
Clin Drug Investig
; 33(1): 11-23, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23208320
11.
Role of cytochrome p450 isoenzymes 3A and 2D6 in the in vivo metabolism of mirabegron, a ß3-adrenoceptor agonist.
Clin Drug Investig
; 33(6): 429-40, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23625188